Dealert› Deals› Life Science REIT

British Land → Life Science REIT

Other Corporate United Kingdom Specialized REITs (NEC) Other / Unspecified
Deal summary

Information on the target

British Land (BLND) has reported a robust set of annual results, showcasing record leasing activity across its campuses portfolio and sustained momentum in retail parks. This performance has driven rental growth, increased earnings, and a more optimistic outlook from management. For the fiscal year ending March 31, 2026, underlying profit rose by 5% to £294 million, while underlying earnings per share (EPS) increased by 1% to 28.9p. The EPRA net tangible assets (NTA) per share also saw a 4% rise to 590p, contributing to a total accounting return of 8.1%, which aligns with the company's through-the-cycle target range of 8-10%. The dividend was raised by 1% to 23.12p.

Chief Executive Simon Carter highlighted the company's strategic focus on campuses and retail parks, where demand is on the rise and supply remains limited. Notably, central London office take-up has reached its highest level in two decades, and British Land's retail parks boast an impressive occupancy rate of 99%. The company successfully leased 3.8 million square feet during the year, with transactions completed at an average of 7.2% above estimated rental values (ERV).

Industry overview in the target’s specific country

The UK real estate market is currently experiencing a bifurcation, with distinct performance trends emerging across different sectors. Prime locations, particularly in London, are witnessing heightened demand driven by a resurgence in office occupancy and retail activity. The ongoing expansion of US technology firms and AI-related businesses seeking international growth opportunities has further bolstered the demand for commercial real estate in the capital.

Retail parks have shown resilience, with a significant shift towards omnichannel retail formats. This evolution is supported by changing retailer requirements and a structurally constrained supply, which has led to positive rental growth. The overall portfolio values have increased by 2.3%, driven by a 4.9% growth in ERV and modest yield compression, indicating a healthy market environment despite some geopolitical uncertainties.

Moreover, the life sciences sector is gaining traction, with British Land positioning itself as a landlord catering to technology, AI, and science-led tenants. The company's recent acquisition of Life Science REIT aligns with this strategy, reflecting a broader trend in the UK market where demand for specialized real estate is on the rise. This sector's growth is expected to continue, driven by advancements in technology and healthcare.

While challenges such as higher bond yields and geopolitical uncertainties may pose risks to the investment market recovery, the underlying occupational fundamentals remain stron…

This is a public preview. The full deal page — disclosed financials, full description, advisers, comparable set — is available with a free account.
Create free account
View primary source ↗